
NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …

The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …
Eisai has published further details of a phase III trial of its first-in-class chemotherapy drug Halaven ahead of its hoped-for …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

